T2 Biosystems WKN: A3EU63 ISIN: US89853L3024 Kürzel: TTOO Forum: Aktien Thema: Hauptdiskussion
T2 Biosystems’ Strong Financials and Strategic Growth Moves In a robust financial update, a company reported a total revenue of $7.2 million for 2023, buoyed by its sepsis and related products, alongside a standout fourth quarter yielding $1.7 million from product sales including the T2Bacteria Panel in the U.S. They also cleared their sepsis test backorder and gained FDA clearances for expanding their diagnostic panel uses. Additionally, they secured a Phase 2 award for their T2Lyme Panel and are progressing towards further FDA submissions. To address Nasdaq compliance, they presented a plan and amended their loan agreement, extending the maturity date and lowering cash requirements. The company also expanded its market reach with exclusive distribution agreements in several European countries and Vietnam.
|
|
Thema | ||
|---|---|---|---|
| 1 | VONOVIA Hauptdiskussion | -0,87 % | |
| 2 | Ecograf - ein Stern am Graphithimmel | -8,57 % | |
| 3 | für alle, die es ehrlich meinen beim Traden. | ||
| 4 | Aktuelles zu Almonty Industries | +3,30 % | |
| 5 | Trading- und Aktien-Chat | ||
| 6 | NRX Hauptforum | ±0,00 % | |
| 7 | Circus SE Inhaber-Akt Hauptdiskussion | +3,98 % | |
| 8 | Stellantis | +0,76 % | |
| 9 | Security der nächsten Generation | -2,52 % | |
| 10 | Germany 40 Hauptdiskussion | ±0,00 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | VONOVIA Hauptdiskussion | -0,87 % | |
| 2 | Ecograf - ein Stern am Graphithimmel | -8,57 % | |
| 3 | Aktuelles zu Almonty Industries | +3,30 % | |
| 4 | NRX Hauptforum | ±0,00 % | |
| 5 | Circus SE Inhaber-Akt Hauptdiskussion | +3,98 % | |
| 6 | Security der nächsten Generation | -2,52 % | |
| 7 | Stellantis | +0,76 % | |
| 8 | Critical Infrastructure Technologies Hauptdiskussion | -3,27 % | |
| 9 | OTL nach dem RS 1:20 | +3,75 % | |
| 10 | DRONESHIELD LTD Hauptdiskussion | -0,29 % | Alle Diskussionen |